EUVIMEDEUVIMED entdecken
Crossref

Ethosuximide lowers lamotrigine serum concentrations: Evidence for a clinically relevant interaction

Anne Hagemann iD, Arne Herting, Dennis Klimpel, Christian G Bien iD, Tilman Polster iD

Epilepsia · 2024

DOI: 10.1111/epi.17952 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2024. Verfasst von Anne Hagemann und 4 weiteren Autor:innen. Beteiligte Einrichtung: Society for Epilepsy Research, Bielefeld, Germany. Hauptthemen laut MEDLINE: Lamotrigine, Ethosuximide, Anticonvulsants, Drug Interactions. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We investigated the effect of comedication with ethosuximide (ESM) on lamotrigine (LTG) blood levels. Based on observations from clinical practice, we hypothesized that ESM reduces the LTG serum concentration. We additionally evaluated this effect in the presence of concomitant valproic acid (VPA). We retrospectively analyzed samples of inpatients from our department who had been treated with a combination of ESM and LTG between 2017 and 2021. We additionally used data on LTG serum concentrations from a previously published cohort from our center. Generalized estimation equations (GEEs) were used for statistical analyses. We included 523 samples from 209 patients. GEE analyses showed that LTG trough serum concentrations were significantly lower in samples with ESM comedication and significantly higher in samples with concomitant VPA. The effect of ESM was moderated by patients' age; in children and adolescents, LTG serum concentrations were 37% lower than in samples without ESM, whereas in adults, LTG serum concentrations were 14% lower. The effect we found in our data is relevant to daily clinical practice, if patients are not seizure‐free despite typical daily LTG dosage, or if they develop side effects during ESM withdrawal. It should be considered especially in children and adolescents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LamotrigineEthosuximideAnticonvulsantsDrug InteractionsHumansFemaleChildMaleAdolescentAdultRetrospective StudiesYoung AdultChild, PreschoolMiddle AgedValproic AcidEpilepsyDrug Therapy, CombinationAged

Stichwörter der Autor:innen

antiseizure medicationdrug levelpharmacokineticvalproic acid

Substanzen

LamotrigineEthosuximideAnticonvulsantsValproic Acid

Autor:innen und Institutionen

  • Society for Epilepsy Research, Bielefeld, Germany.
  • Department of Epileptology, Krankenhaus Mara, Bethel Epilepsy Center, Bielefeld University, Medical School OWL, Bielefeld, Germany.
  • Laboratory Krone, Bad Salzuflen, Germany.

ORCID-Profile: Anne Hagemann, Christian G Bien, Tilman Polster

Zitieren

APA

Hagemann, A., Herting, A., Klimpel, D., Bien, C. G., & Polster, T. (2024). Ethosuximide lowers lamotrigine serum concentrations: Evidence for a clinically relevant interaction. Epilepsia. https://doi.org/10.1111/epi.17952

Vancouver

Hagemann A, Herting A, Klimpel D, Bien CG, Polster T. Ethosuximide lowers lamotrigine serum concentrations: Evidence for a clinically relevant interaction. Epilepsia. 2024. doi:10.1111/epi.17952

BibTeX
@article{Hagemann2024,
  author = {Hagemann, Anne and Herting, Arne and Klimpel, Dennis and Bien, Christian G and Polster, Tilman},
  title = {Ethosuximide lowers lamotrigine serum concentrations: Evidence for a clinically relevant interaction},
  journal = {Epilepsia},
  year = {2024},
  doi = {10.1111/epi.17952}
}
Kostenlos starten →